EichorEICHOR
Location: Chongqing Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Chongqing

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Chongqing University Cancer Hospital · Pfizer · NCT05020236
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · The First Affiliated Hospital of Chongqing Medical Universit · Eli Lilly and Company · NCT07218380
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · The First Affiliated Hospital of Chongqing Medical Universit · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The First Affiliated Hospital of Chongqing Medical Universit · Pfizer · NCT07028853
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Chongqing University Cancer Hospital ( Site 2041) · Merck Sharp & Dohme LLC · NCT06136559
A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Chongqing Traditional Chinese Medicine Hospital · Huabo Biopharm Co., Ltd. · NCT06592274
Indomethacin vs Diclofenac for Preventing PEP
NA · The Second Affiliated Hospital of Chongqing Medical Universi · Air Force Military Medical University, China · NCT07071441
Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chron
Phase 4 · The Second Affiliated Hospital of Chongqing Medical Universi · The Second Affiliated Hospital of Chongqing Medical Universi · NCT06569953
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The Southwest Hospital of AMU · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
Phase 1 · Chongqing University Cancer Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05194982
Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer
Phase N/A · Department of Nuclear Medicine, Daping Hospital of Army Medi · Daping Hospital and the Research Institute of Surgery of the · NCT06284070
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Phase 2 · Chongqing University Three Gorges Hospital · Guangdong Association of Clinical Trials · NCT05536505
Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
Phase 4 · Shapingba District People's Hospital of Chongqing · Shandong First Medical University · NCT06171061
Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · Department of gastroenterology, Second Affiliated Hospital o · Air Force Military Medical University, China · NCT07117318
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · First Affiliated Hospital of Chongqing Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0125 · Bristol-Myers Squibb · NCT07291076
The Chinese Familial Alzheimer's Network
Phase N/A · Capital Medical University · NCT03657732
Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
NA · Daping Hospital, Third Military Medical University · Daping Hospital and the Research Institute of Surgery of the · NCT06633133
Prevention and Intervention of Overweight and Obesity in Preschool Children
NA · Growth,Development and Mental Health of Children and Adolesc · Chen Li · NCT06562465
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The Second Affiliated Hospital of Chongqing Medical Universi · Amgen · NCT07037433
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Chongqing General Hospital · Eli Lilly and Company · NCT07415044
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Phase 2 · Xinqiao Hospital of Chongqing · Xinqiao Hospital of Chongqing · NCT05147844
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (
Phase 3 · Chongqing Cancer Hospital · Fudan University · NCT05909332
Prediction of Extubation Failure: A Multicenter Prospective Observational Study
Phase N/A · The First Affiliated Hospital of Chongqing Medical Universit · Chongqing Medical University · NCT05069441
Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients
NA · Chongqing University Cancer Hospital · Chongqing University Cancer Hospital · NCT05401175
Child-Parent Familial Hypercholesterolemia Screening
Phase N/A · Chongqin Medical University Affiliated Children's Hospital · Children's Hospital of Fudan University · NCT04529967
Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm C
NA · Cancer Center, Second Affiliated Hospital of Chongqing Medic · The Second Affiliated Hospital of Chongqing Medical Universi · NCT07339644
Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study
Phase N/A · the second affiliated hospital of CQMU · Yuehui Yin · NCT07129564
Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NA · Research Site · AstraZeneca · NCT07516184
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · The Second Affiliated Hospital Chongqing Medical University · Eli Lilly and Company · NCT06890598
Look up another city
Look up another condition